Quick Overview: Learn directly from the FDA's regulatory experts in medical product centers: drugs, devices, and biologics. This course is designed ... Kevin Bugin, Deputy Director for Operations for the Office of New Drugs (OND) provides a background and overview of the ... Robert M. Califf, MD, Commissioner of Food and Drugs at FDA, delivers the keynote address to the 2022 Regulatory Education for ...
Cder Redi Annual Conference 2026 - Detailed Overview & Context
Learn directly from the FDA's regulatory experts in medical product centers: drugs, devices, and biologics. This course is designed ... Kevin Bugin, Deputy Director for Operations for the Office of New Drugs (OND) provides a background and overview of the ... Robert M. Califf, MD, Commissioner of Food and Drugs at FDA, delivers the keynote address to the 2022 Regulatory Education for ... Suranjan De, Deputy Director of Regulatory Science Staff (RSS) in the Office of Surveillance & Epidemiology (OSE) presents on ... Kerry Jo Lee, MD, Associate Director for Rare Diseases in the Office of Rare Diseases, Pediatrics, Urologic and Reproductive ... CAPT Connie Jung, Senior Advisor for Policy in the Office of Drug Security, Integrity, and Response (ODSIR), reviews advances in ...
FDA experts: *Review the new BsUFA III commitments, focusing on supplement categories and associated timelines, guidance ... Tamy Kim, PharmD, Director for Regulatory Affairs and Policy in the Oncology Center of Excellence (OCE) describes OCE's ... Register at to learn directly from the FDA's regulatory experts in medical product centers: drugs, ... FDA discusses considerations and best practices throughout a human drug recall life cycle including when to conduct a recall, ...
